Century Therapeutics Inc (IPSC)
2.97
-0.03
(-1.00%)
USD |
NASDAQ |
May 21, 12:25
Century Therapeutics Profit Margin (Quarterly): -3.28K% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -3.28K% |
December 31, 2023 | -14.70K% |
September 30, 2023 | -22.11K% |
June 30, 2023 | -33.63K% |
March 31, 2023 | -1.82K% |
Date | Value |
---|---|
December 31, 2022 | -6.08K% |
September 30, 2022 | -1.38K% |
June 30, 2022 | -2.22K% |
March 31, 2022 | -3.55K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-33.63K%
Minimum
Jun 2023
-1.38K%
Maximum
Sep 2022
-9.86K%
Average
-3.55K%
Median
Mar 2022
Profit Margin (Quarterly) Benchmarks
Verastem Inc | -- |
Entero Therapeutics Inc | -- |
Gritstone Bio Inc | -82.42K% |
Allogene Therapeutics Inc | -295.5K% |
Mirum Pharmaceuticals Inc | -36.52% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -60.31% |
Return on Assets | -33.70% |
Return on Invested Capital | -59.75% |
Operating Margin (Quarterly) | -3.66K% |
Return on Net Operating Assets | -126.1% |